Seong-Eun Kim1, J Scott McNally1, Bradley D Bolster, Jr.2, Gerald S Treimam3,4, and Dennis L Parker 1
1Department of Radiology, UCAIR, University of Utah, Salt Lake City, UT, United States, 2Siemens Healthcare, Salt Lake City, UT, United States, 3Department of Surgery, University of Utah, Salt Lake City, UT, United States, 4Department of Veterans Affairs, VASLCHCS, Salt Lake City, UT, United States
Synopsis
DWI has the potential to provide complementary
information that will allow better discrimination of plaque components such as
lipid core. Iron has consistently been found in
higher concentrations in atherosclerotic plaque compared to vessel tissue. In
previous studies, intraplaque T2* distinguished symptomatic
from asymptomatic plaques in patients with carotid atherosclerosis. In this work we introduce simultaneous measurement of ADC and T2*
using a motion insensitive high resolution 3D multiple echo diffusion weighted driven
equilibrium Stack of Stars sequence. This technique can provide high resolution
T2* and ADC values simultaneously, which may provide important clinical
information to detect plaque progression.Purpose
To develop the motion insensitive 3D
technique for simultaneous measurement of in-vivo ADC and T2* in Atherosclerotic plaque to increase the quantification of high risk plaque components.
Methods
DWI has the potential to
provide complementary information that will allow better discrimination of
plaque components such as lipid core.1 Iron has consistently been found in higher concentrations in
atherosclerotic plaque compared to vessel tissue. It may be incorporated into
hemoglobin or bound to the storage proteins ferritin and hemosiderin, both of
which cause measurable changes in local magnetic field homogeneity. In previous
studies, intraplaque T2* measurement distinguished symptomatic
from asymptomatic plaques in patients with carotid atherosclerosis.2 We have developed a
motion insensitive high resolution 3D
multiple echo diffusion weighted driven equilibrium Stack of Stars (3D ME-DW-DE
SOS) sequence that can simultaneously measure
ADC and T2* of water proton in a single scan. Figure
1 presents the 3D ME-DW-DE-SOS pulse. The
DW-DE consists of an excitation pulse followed by two refocusing pulses and a
tip-up pulse sequence. Two refocusing pulses were designed using three
composite hard pulses. A total of four sets of diffusion sensitized bipolar
gradients were applied. After DW-DE preparation, multiple echo measurements were immediately acquired using the 3D segmented
SOS trajectory. After one excitation three spokes (triple echoes) were acquired.
With the slice partitions
acquired with a centric k-space ordering, the expected signal dependence of diffusion weighted factor b and echo
time is
$$S(\triangle TE,T1,T2^{*},D)=S_{0}(T1,T2)e^{-\frac{\triangle TE}{T2^{*}}}e^{-bD}$$
The diffusion coefficients (D) were constructed
using two diffusion weighted images. T2* decay, due to T2 relaxation and local field
variation, was measured from the triple echo measurements with low b value and ΔTE separation. To test technique feasibility,
MRI studies of five symptomatic and three asymptomatic patients with atherosclerosis were performed on a Siemens Trio 3T MRI
scanner with a home built phased array carotid coils.
The imaging parameters for 3D ME-DW-DE
SOS were: transverse plane, FOV=152x152 mm2, 2 mm slice thickness,
TE/TR = 2.05/8.0ms, bandwidths=560hz/pixel, 32 slices/slab, b =20, 450 s/mm2.
The resultant in-plane spatial resolution was 0.6x0.6 mm2. The total
imaging time was 3 min 20 sec. 3D IR SOS images were
acquired for hemorrhage detection. 3D T1 SPACE with DANTE preparation
measurements were acquired before and after contrast administration. T2* and ADC maps were calculated and displayed using algorithms
developed in IDL (ITT Visual
Information). Mean and standard
deviation values were computed using all pixels identified by ROI for T2* and
ADC. Quantitative
statistical comparison of ADC values from symptomatic and asymptomatic groups
was conducted using unbalanced 1-way
analysis of variance (ANOVA).
Results
Three ROIs per each patient were selected in visible plaque. The mean T2* and ADC values for plaque
obtained from the 8 subjects are summarized in Table 1. Symptomatic plaque had significantly lower T2* values
than asymptomatic plaque (20±2.9
vs. 39±5.8ms, respectively, p<0.002). This value is close to the T2*
value reported previously.
2 Figure 2 displays 3D MPRAGE, 3D T1w SPACE,
T2* and ADC maps from a symptomatic subject with intramural
hemorrhage. The ROI drawn by the red lines in the maps of Figure 2 demonstrate a
typical ROI selection. In this ROI, the measured ADC and T2* values were 0.71±0.17x10
-3mm
2/s and 24±2.29ms, respectively.
Discussion
3D
ME-DW-DE SOS can provide in-vivo T2* and ADC values in atherosclerotic plaque. We found that T2* values were reduced in symptomatic
plaque, consistent with a shift to aggregate iron complexes that have greater
local effects on magnetic susceptibility. The ADC values obtained from
symptomatic plaque were lower than the values of asymptomatic plaque. Further
study will include identifying changes in the amount, species, and chemistry of
intra-plaque iron and their relationship with the changing of the diffusion
properties during the course of atherosclerosis development. The SOS sequence is less sensitive to motion artifacts
due to the repeated high-density sampling of the k-space center with off-resonance
sensitivity.
3,4 The off-resonance sensitivity can be reduced by
increased sampling bandwidth. This paper presented triple echo measurements with
relatively moderate bandwidth. Multiple-echo measurement with more than three echoes
and higher bandwidth may allow gradient timing calibration and multi-point fat-water
separation along with T2* determination.
5Conclusion
The 3D ME-DW-DE SOS can provide high resolution T2* and ADC values simultaneously,
which may provide important clinical information to detect plaque progression.
Acknowledgements
Supported by HL 48223, HL 53696, Siemens Medical Solutions, The Ben B. and
Iris M. Margolis Foundation, and the Clinical Merit Review Grant from the
Veterans Administration health Care System. References
1.
Shinnar M, Fallon J, Wehri S, et al.al e. The diagnostic
accuracy of ex vivo MRI for human atherosclerotic plaque characterization.
Arterioscler Thromb Vasc Biol 1999;19:2756-2761.
2.
Toussaint JF et al. Water Diffusion Properties of Human Atherosclerosis and
Thrombosis Measured by Pulse Field Gradient Nuclear Magnetic Resonance. Arterioscler Thromb Vasc Biol 1997; 17:542-546.
3. Saam T, Hatsukami TS, Takaya N,
Chu B, Underhill H, Kerwin WS, Cai J, Ferguson MS, Yuan C. The vulnerable, or
high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization
and assessment. Radiology 2007;244(1):64-77.
4. Raman SV, Winner MW, 3rd, Tran T, Velayutham M, Simonetti OP,
Baker PB, Olesik J, McCarthy B, Ferketich AK, Zweier JL. In vivo atherosclerotic
plaque characterization using magnetic susceptibility distinguishes
symptom-producing plaques. JACC Cardiovasc Imaging 2008;1(1):49-57.
5. Rasche V, de Boer RW, Holz D, Proksa
R. Continuous radial data acquisition for dynamic MRI. Magn Reson Med
1995;34(5):754-761.
6. Glover GH, Noll DC. Consistent projection reconstruction
(CPR) techniques for MRI. Magn Reson Med 1993;29(3):345-351.
7. Rasche V, Holz D, Proksa R. MR fluoroscopy using projection
reconstruction multi-gradient-echo (prMGE) MRI. Magn Reson Med 1999;42(2):324-334.